Seeking Alpha

Boston Scientific to acquire Bayer unit for $415M

  • Boston Scientific (BSX) has agreed to acquire Bayer's (BAYRY) Interventional device business for $415M.
  • The deal that will strengthen Boston's portfolio of products for treating peripheral vascular disease, with the company to receive systems used in cardiology, radiology and peripheral vascular procedures.
  • The unit generated $120M in sales last year. (PR)
Comments (1)
  • Roxieanne
    , contributor
    Comments (486) | Send Message
     
    I missed the article about the Bayer unit acquisition. Is this the Bayer that makes aspirin.
    1 Sep, 03:15 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|